The development of medical e-commerce in China began in 2005. In September of that year, the State Food and Drug Administration of the United States issued the Interim Provisions on the Examination and Approval of Internet Drug Trading Services, and the term "medical e-commerce" officially began to appear. The "Regulations" have made detailed provisions on the classification, implementation subject and operation mode of medical e-commerce, and since then, the Internet has been opened for drug sales. But in fact, in 1988, China has already opened the first medicine online shop.
Let's take a look at the development of medical e-commerce:
In the embryonic period of medical e-commerce-1998, Shanghai No.1 medical online shop was opened, but unfortunately it was stopped because there was no relevant policy basis;
Medical e-commerce is recognized-in 2000, the State Administration of Pharmaceutical Products formulated the Measures for the Supervision and Management of Pilot Drug E-commerce, which was the first time that the government acquiesced in the existence of drug e-commerce;
Medical e-commerce developed earlier-after five years of pilot, in September 2005, the State Food and Drug Administration of the United States promulgated the Interim Provisions on the Examination and Approval of Internet Drug Trading Services, which stipulated in detail the trading scope, implementation subjects and regulatory standards of Internet drug trading services, so that medical e-commerce can finally go from behind the scenes to the front desk;
The assistance of medical e-commerce-in 2009, the "new medical reform" was officially launched, and medical reforms such as separation of medicines, control of the proportion of medicines, and centralized procurement were officially launched. This environment has given the soil for the continued development of medical e-commerce;
Medical e-commerce braked suddenly —— In July, 2065438+06, the State Food and Drug Administration of the United States ended the pilot of the third-party platform for Internet transactions, and recovered the pilot of 1 and 800 square meters;
On the eve of the outbreak of medical e-commerce -2065438+2007 1 the State Council issued a document to cancel the examination of B and C certificates of medical e-commerce, which means that the regulatory policy for medical e-commerce is relaxed; In September of the same year, the State Council subsequently cancelled the examination and approval of Internet drug trading service enterprises (third parties) /A certificates. Liberated the entry threshold for medical e-commerce.
Medical e-commerce related policies:
According to the statistical analysis report of pharmaceutical circulation industry of Ministry of Commerce in 20 16, the total sales of pharmaceutical e-commerce direct reporting enterprises in 20 16 was 61200 million yuan, of which the sales of B2B business was 57.6 billion yuan, accounting for 94.2% of the total sales of pharmaceutical e-commerce; The sales of B2C business is 3.6 billion yuan, accounting for only 5.8% of the total sales of medical e-commerce. The platform is positioned as Putian Medical Machine Network, focusing on becoming a sunshine procurement platform for private hospitals in China and a public service platform for health industry. 20 17 submitted the report card with the transaction volume exceeding that of 50 yuan, which is a positive signal for the development of medical e-commerce, indicating that the time has come for the rapid development of medical e-commerce!
At present, the national two-vote system, the reform of the camp, the separation of medicines and other policies have been fully infiltrated, and modern people are completely accustomed to the online shopping model, so the e-commerce model is likely to be a strong opponent that impacts the traditional drug circulation model. In terms of volume, the development of medical B2B may be earlier than that of medical B2C model. Moreover, it has been proved that the B2B era of medical e-commerce is coming.
Behind the spurt growth of transaction volume, more reflects the needs of the industry. For example, Putian Medical Machine Network can not only help buyers optimize their purchasing needs, intelligently match the best products, and realize the seamless fit of the industry supply chain; It can also provide a third-party B2B e-commerce platform for pharmaceutical circulation, which integrates product release, activity promotion, channel distribution, customer relationship management and inventory management. Some industry analysts believe that the nationwide development of pharmaceutical B2B has reached a climax. It seems that this time the era of pharmaceutical e-commerce has really come!
Under the current medical reform environment, policies such as separation of medicines, control of the proportion of medicines, multi-level medical system construction, medical payment reform, centralized procurement, new GSP, flight inspection, consistency evaluation, and two-vote system have been gradually promoted, involving all aspects of drug research and development, production, circulation, sales and use, which has also promoted the development of pharmaceutical e-commerce.
The future development of medical e-commerce may have the following directions:
The first is to meet the needs of accessible target groups, such as contraceptives, young health products, household appliances and so on.
The second is to extend offline with the strategy of strategic layout and grading, build big warehouse pharmacies, connect with medical insurance, and seize the entity chain pharmacy market on a large scale.
The third is to become the trustee of hospital pharmacy and assist the government to complete the separation of medicine.
The fourth is to connect with community health and cooperate with offline to complete disease prevention and chronic disease medication for consumers.
Fifth, through the acquisition, analysis and application of big data, through professional departments, using brand promotion and group lectures of medical experts, directly face consumers and build a health management system.
The sixth is to help pharmaceutical companies complete regional or national sales layout.
In the future, the competitive pattern of the pharmaceutical market will be a combination of online and offline, including pharmaceutical e-commerce, hospitals, pharmacies, outpatient clinics and so on. Therefore, in the future, medical e-commerce will usher in greater opportunities and challenges.